HealthSouth (HLS) Misses Q1 EPS by 12c, Reaffirms Guidance

HealthSouth (NYSE: HLS) reported Q1 EPS of $0.44, $0.12 worse than the analyst estimate of $0.56. Revenue for the quarter came in at $740.6 million versus the consensus estimate of $731.3 million.

2015 Guidance

In a Current Report on Form 8-K dated March 27, 2015, the Company reiterated its Adjusted EBITDA guidance of $670 million to $680 million for 2015 and revised its earnings per diluted share guidance to a range of $2.13 to $2.19 per share to include the impact of the March and April 2015 debt transactions discussed above and the March 2015 agreement to settle the General Medicine lawsuit. Based on its results for the first quarter of 2015, including the atypical litigation settlements and increase in bad debt expense discussed above, the Company affirms its 2015 Adjusted EBITDA and earnings per share guidance

For earnings history and earnings-related data on HealthSouth (HLS) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Pro Diversity Network (IPDN) Reports Q2 Loss of $0.15
• SanDisk upgraded at JPMorgan after investor day; shares climb